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Abstract 
Primary care providers (PCPs) are responsible for the medical management of patients with 
chronic illness. There are national guidelines issued by expert panels to enable PCPs to offer 
evidence based medical care to their patient population with chronic illnesses. Unfortunately, 
many PCPs do not adhere to these guidelines. This quality improvement(QI) project was 
designed to use the Awareness-to-Adherence theory in a Plan-Do-Study-Act (PDSA) cycle to 
strengthen the PCP understanding of the American Diabetes Association (ADA) guideline for the 
testing frequency of the Glycosylated Hemoglobin A1c (A1c) in patients with diabetes mellitus 
Type 2 (DM2). The patients were selected randomly from the electronic health record (EHR) of 
two rural primary care settings in Sullivan County, New York. The sample consisted of 22 male, 
and 26 female Caucasian adults (48 total) with well-established DM2. Each patient had, or 
should have had a baseline A1c drawn in the quarter immediately preceding the beginning of the 
QI project (October, November, December, 2013). A preview of the EHR revealed the PCPs 
ordered the A1c per ADA national guidelines on 37% of their patients with DM2. This QI 
project initiated an educational intervention which highlighted 1) the importance of A1c testing, 
2) the concept of clinical inertia, and 3) reinforced the ADA guideline for testing patients with 
DM2. The PCPs used this information to decide if, and when to order an A1c on their patient 
population with DM2. After the intervention the PCPs ordered the A1c per ADA guidelines on 
65% of patients with DM2. This represents a net gain of 28%. Further clarification of when to 
order the A1c in patients whose levels ≤7% is needed. Monitoring  A1c levels will reduce the 
incidence of co-morbidities, and health care costs in this patient population. 
Keywords: hemoglobin A, glycosylated, guideline adherence, practice guidelines as topic, 
diabetes mellitus type 2, and medication therapy management. 
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The Adherence of Primary Care Providers to the American Diabetes Association Guideline for 
Frequency of A1c Testing 
Introduction and Background 
The History of the Use of the A1c in Diabetes Treatment  
 The process of separating hemoglobin into its constituent components was discovered in 
1955 (Little, & Rohlfing, 2013). Subsequently, further research found one component, the 
Hemoglobin A1c was found to be elevated in patients with diabetes mellitus (Koenig, et al., 
1976). The knowledge of this correlation led investigators to discover if it could be useful in the 
diagnosis or treatment of diabetes mellitus. In 1984 Nathan, Singer, Hurxthal, & Goodson added 
to this growing body of knowledge of the significance of the Hemoglobin A1c by demonstrating 
that the A1c assay could be an important tool for the clinician to evaluate the long-term glucose 
level of the patient. However, since a standard process had not been established there was neither 
a central reference, nor an absolute value to use as an accurate, and reliable reference point. In 
fact because there were so many varied ways to test the assay a method of comparing data from 
one laboratory to another did not exist (Little, & Rohlfing, 2013).  
 Clearly, further examination of the A1c was needed. Therefore, the National Institutes of 
Health through its National Institute of Diabetes and Digestive and Kidney Diseases division 
conducted a 10 year study (1983-1993) of 1441 patients. This study known as the Diabetes 
Control and Complications Trial (DCCT) only included subjects with diabetes mellitus Type 1. 
However, its results have significant implications for all patients with diabetes. Notably, DCCT 
established the importance of maintaining a patient's A1c to a normal level (6%) to drastically  
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reduce the risk of complications to the cardiovascular, renal, neurological, ophthalmologic 
systems. In addition, the follow-up study-Epidemiology of Diabetes Interventions and 
Complication (EDIC) - continued to track the health of 90% of the study's participants. EDIC 
participants who maintained intensive control of the glucose and maintain A1c levels of 6%-7% 
continued to show reduced risk of cardiovascular complications. Prior to, and concurrent with 
the DCCT, the United Kingdom Prospective Diabetes Study (UKPDS) was a 20 year research 
effort from 1977 to 1997. The UKPDS had 5,102 participants who were diagnosed with Diabetes 
Type 2. It studied the effect of tight glucose, and blood pressure control in this population to 
ward off complications that were previously thought of as "inevitable" e.g. complications in the 
cardiovascular, neurological, renal and ophthalmologic systems. Once again, glucose control 
with a A1c between 6%-7% was shown to be the key to reducing complications from diabetes.  
How the ADA Incorporated the A1c into the Standard of Medical Care  
 The ADA has included parameters for the use of the A1c since 1997 in their annual 
Standard of Medical Care (ADA, 1997). The most recent edition of the Standard for Medical 
Practice  (2013)  states the A1c test is " the gold standard" in diabetes management for optimal 
patient care (ADA, 2013). The test has several indications for clinical use including: diagnosing 
diabetes mellitus (diabetes), diabetic screening, as a guide to adjust treatment (diet, medications, 
etc.), and to evaluate the effectiveness of ongoing therapy (ADA, 2013). The test measures a 90-
120 day average of how much glucose has come in contact with the hemoglobin molecules on 
the red blood cell. Normal ranges for the A1c test are 5.5% - 7.0 % (ADA, 2013). The ADA 
guideline suggests A1c testing should be done semi-annually for stable patients, identified as 
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those whose values are < 7.0%, quarterly for patients whose A1c is(≥7.0%), or three months 
after a treatment change to assess the effectiveness of new treatment (ADA, 2013).  
Problem Statement 
 The management of DM2 within primary care offices should adhere to the ADA 
guideline to obtain the optimal health outcomes for the patient. Unfortunately, many PCPs do not 
adhere to the recommended A1c testing schedule as outlined by the ADA. The ADA has 
specified  intervals for the testing of the A1c for optimum monitoring of a  patient's glycemic 
control. Timely A1c testing is important because patients with poorly controlled DM2 diabetes 
are at increased risk of urinary tract infections, fungal infections of the mucous membranes and 
skin, hearing impairment, osteoporosis, erectile dysfunction, glaucoma, peripheral amputations, 
neuropathy pain, non-healing wounds, and diabetic ulcers (Mayo Clinic, 2013).   
 
Diabetes in the United States 
Evidence of the Problem 
 In 2011 there were approximately 26 million diabetics in the United States (CDC, 2011). 
The annual direct, and indirect cost of diabetes consist of average medical costs, lost wages, 
disability, and premature death is estimated to be $174 billion dollars (CDC, 2011). Worse still is 
the effect diabetes has on the patient's body. The increased saturation of the large glucose 
molecules in the patient's blood stream affects the macrovascular systems, and raises the risk of 
cardiovascular disease including hypertension, and CVA. The long term complications are due to 
endothelial damage to the microvascular system (Krishna, Gillespie, and McBride, 2010; Mayo 
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Clinic, 2013). The National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) 
estimates approximately 230,000 Americans die from complications of diabetes (2011). 
Diabetes Rates in Sullivan County, New York 
  In 2013 the Sullivan County, New York the age adjusted mortality from diabetes mellitus 
per 100,000  stands at 22.9; the age adjusted mortality rate for New York state is 14.9 (County-
By-County Rankings, 2013). Additionally, hospitalization for diagnoses where diabetes was a 
factor was 262.6 per 10,000, whereas the New York State age adjusted rate was 224.8 per 10,000 
(Sullivan County Public Health Services, 2010). The disease burden upon the residents of 
Sullivan County (population 77,000) is deleterious, with 9.4% of the adult population diagnosed 
with DM2, whereas the diabetes rate in New York State is 8.2% (Sullivan County Public Health, 
2013).  
Identification of the Problem in the Geographic Area of the QI Study 
 Western Sullivan County is comprised of the towns of:  Callicoon, Cochecton, Delaware, 
Fremont, Highland, and Tusten it has a population 12,567 (Sullivan County Public Health 
Services, 2010). The area is federally designated as a Primary Care Health Professional Shortage 
Area (US Department of Health and Human Services, 2013). In western Sullivan County the 
problem of poor diabetes management is exacerbated by the absence of endocrinologists to 
provide specialized care to the diabetics in the region. The closest endocrinologist offices from 
western Sullivan County are over thirty miles away. Additionally, the dearth of public 
transportation, or mass transit systems in the western portion of the county hampers access to 
endocrinologists. Therefore, management of diabetes in western Sullivan County is handled 
within 3 primary care offices. This QI project included the PCPs of two of these offices. Rural 
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areas such as this are known to have patient populations with the health care disparity in higher 
incidence of diabetes, less access to specialized medical care, minimal if any access to diabetes 
educators, and fewer options for engaging in activities that will increase physical activity 
(Massey, Appel, Buchanan, & Cherrington, 2010).   
Demographics of  Western Sullivan County 
 The population of western Sullivan County stands at 8,714. The majority of the patient 
population (71.2%) are Caucasian, and are descended from  the original European settlers of the 
area. The ancestry of the patients are: Irish (19.7%), German (18.7%), and Italian (13.5%)  
(Sullivan County Public Health, 2010). The average educational attainment is high school 
completion (Sullivan County Public Health Services, 2013), and the median annual income for a 
family of four is approximately $62,000, which is $24,900 below the New York State median 
income of approximately $87,400 (US Census Bureau, 2014). There are three primary care 
offices located in the area. Two are owned, and operated by Catskill Regional Medical Center 
(CRMC) which is the sole hospital provider for the county; the other is a private practice. The 
two offices owned by CRMC are nurse practitioner led primary care family health centers. This 
QI project took place in these two nurse practitioner led primary care offices. 
  Theoretical Framework: The Adherence-to-Awareness Model 
 Pathman, et al. (1996) used physician non-adherence to the national guideline for 
childhood immunizations as a model to develop a theoretical framework to address physician 
non-adherence to guidelines. In this model Pathman, et al. identified "the sequential, cognitive, 
and behavioral steps" needed to achieve physician adherence to guidelines as "awareness, 
agreement, adoption, and adherence" (p 875 para 2; Figure 1 ). 
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Pathman Sequence to Physician Guideline Adherence 
Awareness →Agreement →Adoption →Adherence 
Figure 1 
Awareness Agreement Adoption Adherence 
Physicians must 
become aware of the 
existence of the 
guideline. 
Dissemination of the 
guideline is critical. 
Physicians must agree with the 
soundness of the guideline. If 
physicians do not agree with 
the health benefit the sequence 
is "frozen" and cannot advance. 
Although physicians 
may adopt the guideline 
due to peer pressure or 
to avoid malpractice 
suits, Pathman, et al. 
posit most physicians 
adopt guidelines 
because they have 
become aware of it, 
have researched it, and 
agree with its value in 
promoting or 
maintaining patient 
health.  
Pathman, et al acknowledges that 
adoption and adherence have become 
more prevalent as practices are 
increasingly under scrutiny from CMS 
and insurers. However, Pathman, et al. 
states it "is reasonable to conclude most 
physicians are in voluntary compliance 
with the guidelines. 
 Pathman, et al. (1996).
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This work was augmented by Cabana et al. in 1999. Cabana et al. (1999) did not develop a new 
theory, rather Cabana, et al. (1999) expanded the three step sequence used by Pathman, et al. into 
a broader, and multi-directional flow which illuminates the cognitive dissonance that lead to the 
barriers that manifest as physician non-adherence to guidelines (Figure 2). Cabana et al.'s 
expanded pathways are: 1) "lack of knowledge includes: lack of awareness, or lack of 
familiarity; 2) attitudes about the guideline includes: lack of agreement, lack of self-efficacy, 
lack of outcome expectancy, or the inertia of previous practice; 3) behavior: these are external 
barriers" (1999 p 1460 para 5).  
Figure 2 
 
 When assuming diabetes management of a rural population it is crucial that the ADA 
guideline is followed to ensure the highest level of care is provided to patients. Unfortunately,  a 
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study using the US National Ambulatory Medical Care Survey shows of all patients whose 
accompanying disease IC9 code indicates a diagnosis of diabetes mellitus (250.00-250.93) only 
27%  of all office visits included an order for A1c testing (Neumillier, et al., 2010).  
 This DNP Capstone quality improvement project seeks to increase PCP adherence to the 
ADA guideline for A1c testing by increasing the knowledge of the PCP of the rationale behind 
the guideline (awareness), teach how the A1c value can be used in clinical treatment decisions 
(agreement), and how to incorporate the A1c value in their patient education to increase patient 
awareness of the importance of glycemic control (adoption). In addition, a 10 question pre/post 
test was designed to test the augmentation posited by Cabana. Questions were formed to test lack 
of awareness, or familiarity, attitudes that could lead to a lack of agreement or clinical inertia, 
and behaviors that are external barriers to adherence to the ADA guideline.  
Review of Literature 
Awareness of Guideline/Lack of Familiarity with the Guideline 
  Pathman (1996) posits the first step toward adherence is knowing the guideline. The 
National Clearinghouse of Guidelines is the pre-eminent source for all members of the healthcare 
community (US Department of Health and Human Services, nd). Its database of evidenced based 
practice is freely available to the public (US Department of Health and Human Services, nd). 
Parcero, et al, 2011, Neumiller, et al.,2010 and McClellan, et al.,2003 all agree the low 
adherence to national guidelines is the result of lack of knowledge about the existence of the 
guideline, and its objectives. Glasser, 2010 discusses the low adherence rate (< 50%) in which 
only 21% of the patient population had a recorded A1c value over their two year chart review. 
McClellan, et al. (2003) concurs, and states the dissemination of knowledge about the existence 
of guidelines could be improved upon with including educational materials in the billing , and 
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remittance packets sent to providers from the Centers for Medicare and Medicaid Services 
(CMS). In addition, McClellan, et al. (2003) found even among PCPs who were aware of the 
ADA guideline, there was low documented evidence of the PCP following the guideline, this the 
researcher determined indicates lack of agreement with the guideline. In his survey of 195 
patients Delaronde (2005) found 38.1% of the respondents answered with the response  "My MD 
never told me I need at least 2 A1c tests per year". Compounding an additional 33.3% of 
respondents chose "I have never heard of the A1c test" as their answer. This lack of 
awareness/lack of familiarity of the PCP with the ADA guideline is confirmed by the data 
analysis of Neumiller, et al. (2010) whose use of the US National Ambulatory Medical Care 
Survey shows in 2005 only 27% of all diabetic patients had an ordered A1c in their patient health 
record.  
Agreement with Guideline/Lack of Self-Efficacy About the Guideline: 
  According to Parcero, et al., 2011, and Schafer, 2006 adherence to the ADA guideline 
increases glycemic control, and reduces the incidence of co-morbities related to DM2. 
Unfortunately, the lack of self-efficacy on the part of PCPs leads to clinical inertia. Clinical 
inertia is described as provider's unwillingness, or inability to intensify medication treatment in 
patients whose glycemic control is non-therapeutic (Schaefer, 2006). Clinical inertia is not  
related to patient non-adherence to ordered treatment. Clinical inertia is the provider's failure to 
advance medication management needed to maintain A1c levels of ≤7% (Schaefer, 2006). 
Cabana, et al.(1999) identifies clinical inertia as an attitude barrier, which is directly attributable 
to lack of self efficacy. This barrier requires both knowledge, and a change in provider behavior 
to end the state of inertia. Vigersky (2011), and Davis, Chavez, & Juarez (2014) state lack of 
belief of self efficacy (clinical inertia) prevents the PCP from intensifying the medication 
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regimen even when they fully understood the long term danger this meant for the patients. 
Furthermore, Davis, Chavez, & Juarez (2014) report only 21% of patients with an A1c between 
8%-9% had their treatment intensified. Whereas, Vigersky (2011) reports a lack of self efficacy, 
or clinical inertia resulted in an average lag of 20 months before treatment was intensified in 
patients with A1c ≥ 8%. Both teams of researchers conclude lack of self-efficacy (clinical 
inertia) can lead to a lag of nearly 2 years before the PCP initiates a change in medication 
regimen due to lack of agreement with the guideline. 
Adoption of the Guideline/Agreement With the Guideline 
  Khoong, Gibbert, Garbutt, Sumner, &Brownson (2014), Parcero (2011), Massey, et al., 
(2010), Heisler, Piette, Spencer, Kieffer, &Vijan, (2005), and Siminero (2005) all affirm that 
PCP agreement with the guideline is necessary for full adoption of the guideline. With adoption 
of the ADA guideline PCPs fully acknowledge the A1c is the principle method to monitor the 
glycemic index, and increases the patient's glycemic control (Parcero, 2011; Heisler, 2005). With 
agreement, and adoption PCPs correctly perceived the barriers to diabetes management, and the 
need to overcome them (Siminero, Piatt, and Zgibor, 2005), PCPs use the A1c to make a 
significant change in the patient's diet, recommendations for exercise, and intensify medication 
(Heisler, et al, 2005). In addition, PCPs who understand the ADA guideline are more likely to 
engage in novel approaches to reach patients through community, and web based interventions 
(Massey, Appel, Buchanan, & Cherrington, 2010).  
 Clearly historical, and contemporary evidence establishes a pattern of lack of physician 
adherence to the ADA guideline regarding the frequency of A1c testing in primary care. 
Additional evidence points to the increased morbidity, and mortality when a patient has poorly 
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controlled glycemic levels (Davis, Chavez, & Juarez, 2014, ADA, 2013, McClellan, et al., 2003).
 This QI project embraces the model of Pathman, et al (1996) by adhering to the sequence 
of awareness, agreement, adoption, and adherence by the PCP; as well as the expanded pathways 
of Cabana, et al.(1999) lack of familiarity, lack of agreement, and behavioral barriers. 
Method 
Quality Improvement Project Description, and Study Design  
   Plan-Do-Study-Act 
      The Plan-Do-Study-Act (PDSA) cycle is a Model for Improvement that is an appropriate 
method for quality improvement projects in health care settings (Institute for Healthcare 
Improvement, 2011). The PDSA cycle (Figure 3) involves identifying a specific measure to 
change and then to implement and ”test the change in the real work setting - by planning it, 
trying it, observing the results, and acting on what is learned" (Institute for Healthcare 
Improvement, 2011). The aim of using the PDSA cycle on a small project is to refine the quality 
improvement project, and advance through the cycles several times to eventually implement the 
change on a wide scale basis throughout a larger healthcare system (Institute for Healthcare 
Improvement, 2011).  
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Figure 3                                          Plan-Do-Study-Act Cycle 
 
© Copyright NHS Institute for Innovation and Improvement, 2008 
The steps are: 
• Plan- Gathering baseline data for the quality improvement, and posit what will occur 
once the project is implemented; Secondly, this stage requires a plan to test the quality 
improvement change 
• Do- Execute the project on a small scale. Revise this process as problems arise, and 
document this process. At this stage the data analysis can begin; 
• Study- Adequate time must be set aside to analyze the data; 
• Act- Analyze the data and plan a revision and restarting the PDSA cycle (Institute for 
Healthcare Improvement, 2011). 
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Project Setting 
      The setting for this QI project was at two primary care offices, which are owned and 
operated by Catskill Regional Medical Center (CRMC): the Callicoon Family Health Center, and 
the Livingston Manor Family Health Center. Both offices are located in rural, western Sullivan 
County, New York. The PCP in each of these offices a Family Nurse Practitioner.  
Study Participants 
  The study participants are two nurse practitioners who are employed by CRMC, and are 
the PCPs in the family care centers in western Sullivan County, NY. The PCP in the Callicoon 
Family Health Care Center is a doctorally prepared nurse practitioner, and the PCP in the 
Livingston Manor Family Health Care Center is a master's level nurse practitioner 
Protection of Human Subjects  
 Due to the need to collect data about the ordering practice of the PCPs patient data must 
be obtained. Permission to access the EHR was obtained from the Vice President of Nursing at 
Catskill Regional Medical Center. All patient data was protected as stipulated by HIPPA law 
(US Department of Health and Human Services, 2003). No identifying patient data was divulged 
during, or after the course of this QI study (US Department of Health and Human Services, 
2003).  
Patient Population 
 In each practice, the ages of the patients with DM2 range from 30-90 years old, with a 
mean range of 30-80 years of age. The patients at the Callicoon Family Health Care Center are 
predominately Caucasian with ancestry from Germany, Poland, and Italy. The patients in the 
Livingston Manor Family Health Center are evenly divided between patients with Hispanic 
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ancestry, and those with ancestry from Italy, the British Isles, and Germany. These demographic 
mirrors the overall demographic of Sullivan County (US Census Bureau, 2014).  
 A random sample of patients was collected from the EHR of the practices. Criteria for 
inclusion in the study were adult patients with a documented history of DM2 who had, or should 
have had a baseline A1c drawn in the quarter immediately preceding the start of this QI study 
(October, November or December, 2013). The sampling yielded 60 names, however only 48 of 
these patients had, or should have had a baseline A1c drawn in the baseline timeframe  (Table 1).  
Table1                                               
           Period Data 
Collected 
 
Percentage 
   
Patients with A1c recorded in EHR during baseline quarter   44 
 
91.6% 
Patients with A1c not recorded in EHR during baseline period 4 8.3% 
   
Total 48 100% 
 
Protection of Identifying Information  
 The patient's names were converted to numbers to protect their identity.  A master log 
was created with the names of the patients, their number, and the date of their most recent A1c 
level (Table 2). This log was kept in the possession of the project manager in a locked, secured 
location to protect the patient's right to privacy in accordance to HIPPA law (US Department of 
Health and Human Services, 2003). Of the 60 patients, 48 had, or should have had a recorded 
A1c levels in the quarter preceding the beginning of the QI project (October, November, and 
December, 2013). The data from these 48 patients was used in this project (Table 1).   
Table 2                                 Sample of Master Log of Patient Data 
Patient Name Assigned Number Baseline date A1c Date Due     Completed 
John Doe 001 10/2013                8.1 01/2014              01/21 
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Pre-QI Project 
Project Design 
 This projects aimed to increase PCP adherence to the testing frequency of the HgbA1c of 
adults with DM2. During the project:  
• 1) Each PCP took a pre-test which was based upon Cabana, et al. (1999) expansion of 
the Awareness-to-Adherence theory to determine the baseline level of knowledge, self-
efficacy, and behavioral barriers to utilizing the ADA guideline for A1c monitoring. 
• 2) Each PCP viewed a PowerPoint presentation as an educational component to 
introduce the ADA guideline of A1c testing frequency, the concept of clinical inertia, 
and to identify the project objective (Appendix A). 
• 3) Each PCP was given the opportunity to ask questions to verify they understood the 
goal of the QI project was to order an A1c according to the ADA guideline 
• 4) Each PCP used a sheet supplied by the project manager to record the name of each 
patient with DM2, and the date the A1c is ordered. This sheet was placed into a binder 
and protected from view to comply with HIPPA laws.   
• 5) At the conclusion of the project each PCP completed the post-test to determine if the 
project has increased PCP adherence to the ADA guideline for A1c testing.  
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Plan: Educational Components 
 The pre/post-test (Figure 4 ) was designed to assess the PCPs current level of  adherence 
to the ADA A1c testing frequency using the Cabana (1999) expansion of the Pathman model.  
Figure  4                                   Pre/Post Study Test 
Question Strongly 
Disagree 
Tend to 
Disagree 
Neither 
agree 
nor 
disagree 
Tend to 
Agree 
Strongly 
Agree 
1. Describe your familiarity with the ADA DM guideline: 
2. I offer high quality care in 
my office. 
     
3. I like to use national 
guidelines to make treatment 
decisions. 
     
4. I believe national guidelines 
are helpful when making 
treatment plans. 
     
5. How frequently do you 
assess A1c in patients with 
"unstable" DM (e.g. A1c ≥ 7%) 
 
Yearly Monthly Quarterly Semi-
Annually 
Other 
6. How frequently do you 
assess A1c in patients with 
stable DM yearly, monthly, 
quarterly, semi-annually, or 
other? 
Yearly Monthly Quarterly Semi-
Annually 
Other 
7. A current A1c is helpful in 
developing treatment decisions 
for my diabetic patients 
     
8. It is important to know a 
diabetic patient's A1c when I 
make treatment options. 
     
9. In the future, utilizing a 
current A1c will be an integral 
part of my clinical treatment 
decisions. 
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10. Please use this space to answer this question: Please describe any barriers that exist in 
your practice to measure A1c for your patients with DM2. 
 
 
 
 
 Questions 1-4 assess knowledge/awareness of the ADA guideline, questions 5-9 assess 
self-efficacy, and outcome expectancy of the PCP when utilizing the ADA guideline's 
recommendation of frequency of A1c testing and questions, and question10 assesses the effect of 
external barriers upon the behavior of the PCP when trying to adhere to the guideline. After the 
pre-test the project manager presented a PowerPoint to introduce the ADA guideline of 
frequency of A1c testing, the concept of clinical inertia, the rationale for adhering to the 
guideline for A1c testing. After this presentation each PCP was given a handout for quick 
reference in their office, and the objective of the QI project was fully explained to the PCP. The 
objectives of the QI project were:  
    a) To recognize the value of the ADA national guideline testing recommendation  for 
 obtaining  the A1c 
 b) To order an A1c in accordance with the ADA frequency guideline. 
Plan: Obtaining Baseline A1c Values  
 The patient names, their number and the baseline values were entered into a log(Table 4) 
which was kept in a secure, locked location known only to the project manager. This protection 
of identifying patient information was in accordance with HIPPA law (US Department of Health 
and Human Services, 2003).   
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Table 4                                          Compilation of Baseline Values 
Baseline A1c Data 
Collected 
 
Percentage 
   
Patients with A1c ≤ 7% at baseline 21   44% 
   
Patients with A1c ≥ 7% at baseline                                                                                                         23 48% 
   
Patients without a baseline A1c who should have had one at baseline 4   8% 
   
Patients whose A1c values were collected as per ADA guideline 48 37% 
   
   
Total 48      100% 
 
Do: Start of the QI Project 
 The project began in January, 2014. Each PCP had their HIPPA protected sheet, recorded 
the names of the patients with DM2 who came to visit, and if they ordered an A1c for the patient.  
Do: Project Mid-Point 
 At the mid-point of the QI project the project manager reviewed the list of patients with 
DM2 who had been seen by the PCP. The list was compared to the master log to determine if  
each PCP followed the objectives of the QI project: ordering a current A1c in accordance to the 
ADA guideline.  
Do: Remediation  
 To reinforce the QI objectives a second presentation of the PowerPoint, study objectives, 
and review of factors that foster clinical inertia was completed with each PCP for remediation.  
 
 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         21 
 
Study: Data Analysis 
 At the conclusion of the project, the post-test (Figure 2)was given to each PCP to assess 
if there is was a change in their knowledge, self-efficacy, and if they identified behavioral 
barriers which impeded their adherence to the ADA guideline for frequency of A1c testing.  
Act: Recommendation  
 Possible recommendation forwarded to Vice President of Nursing for expanded 
implementation of QI project. The final project will be submitted to the Capstone committee, and 
each PCP.  
Timeline and Budget 
      The project was conducted between January, 2014 and March, 2014. The timeline is 
divided into five stages. Each step embodies a portion of the cycle of the Plan-Do-Study-Act 
cycle of the project design model.  
Step 1 January, 2014 (Plan) 
• Administer pre-test to each PCP,   
• PowerPoint presentation to each PCP,   
• Review QI project objectives with study participants,  
• Select random sample. 
Step 2 January, 2014 (Do) 
• Study participants resume clinical duties with expectation PCPs will fulfill study 
objectives. 
• Return to the office to interview the PCP to see if objectives are being followed,  
• Remediation with review of PowerPoint, study objectives, review of clinical inertia. 
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Step 3 March, 2014 (Study) 
• Post-test with PCPs 
• Collect all data 
• Analyze qualitative data, identifying common themes, and prepare final report. 
 Step 5 April, 2014 (Act) 
• Issue final report to 0the Capstone committee, Vice President of Nursing and study 
participants. 
Budget 
        The study participant declined the honorarium, thus the total budget for this project was 
$50.00 which was the cost for paper products, gas to travel, and binders. 
Findings 
Data Analysis 
 Prior to the beginning of this QI project the project manager used the EHR of the 
practices to randomly select the names of 60 adult patients with DM2. Of these, 48 patients had, 
or should have had an A1c drawn in the baseline quarter (October-December, 2013). The final 
sample had 22 male patients and 26 female patients with age range from 34-91 years. The 
patient's ethnicities were Caucasian with ancestry from Germany, the British Isles, and Poland 
(86%), African- American (8%), and Hispanic with ancestry from Puerto Rico, Mexico and 
Central America (6%).  
Results 
 According to Pathman, et al. (1996) PCP non-adherence to guidelines is due to a 
cognitive dissonance of awareness, agreement, and adoption within the PCP. Pathman, et al. 
(1996) posits the addition of education to help the PCP understand the importance of the 
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following the guideline aids the PCP to move along the continuum from awareness to adoption.
 Prior to the QI project the PCPs correctly ordered A1c levels on 37% of the sample of 
patients collected from the EHR. After the QI intervention of an educational program (shown 
successive times), identification of the importance of obtaining an A1c on patients with DM2, a 
clear understanding of the need to break clinical inertia the PCPs correctly ordered A1c levels on 
65% of their patients. This represents a net gain of 28% of A1c tests ordered in adherence to the 
national guideline (Table 5).  
Table 5                                         Post-QI Intervention Data Results 
ADA Guideline Criteria Data 
Collected 
 
Percentage 
   
Baseline A1c ≤ 7% with early repeated A1c values taken during QI project   8 17% 
 
Baseline A1c ≥ 7% NOT taken during QI project 
    
  9 
 
19% 
 
Baseline A1c ≥7% taken during QI project 
 
 15 
 
31% 
 
Baseline ≤ 7% not repeated during QI project 
 
 13 
 
27% 
 
Baseline data who had A1c collected during QI project 
   
  3 
   
   6% 
 
Patients whose A1c was ordered as per ADA guideline 
 
 31 
 
65% 
   
Total                                                                                                                     48 100% 
 
     Pre-Post Test Results 
 Cabana, et al.(1999) expanded upon Pathman idea and proposed the path from non-
adherence to adherence to guidelines lies not on a linear continuum, but rather on a multi-
directional flow. Review of the pre-test shows both PCPs intent is to provide high quality care to 
their patient population. However, on the pre-test (Figure 2) they both indicate a slight hesitance 
to use national guidelines indicated by choosing "Tend to agree" as their answer on the pre-test.  
However, on the post test both PCPs indicate they strongly agree with questions relating to 
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knowledge of national guidelines (Questions 1-4). Questions 5-9 investigate the PCP attitude 
when using national guidelines, negative answers on these can indicate level of outcome 
expectancy. On the pre-test the majority of the PCP answers were neither agree nor disagree. 
This ambivalence changed on the post test when both PCPs chose strongly agree for all 
questions.  Responses to the pre-test for each PCP is shown in Table 6 and 7.  
Table 6                                                        PCP 1 Pre Test 
 
Question Number 
 
Strongly 
Disagree 
 
Tend to 
Disagree 
 
Neither 
Agree nor 
Disagree 
 
Tend to 
Agree 
 
Strongly 
Agree 
1     Familiar 
with 
guideline, I 
don't stick 
to it 
2     x 
3      x 
4     x 
5 Yearly 
 
Monthly Quarterly 
x 
Semi-
Annually 
Other 
6 Yearly 
 
Monthly Quarterly Semi-
Annually 
x 
Other 
7 Strongly 
Disagree 
 
 
Tend to 
Disagree 
Neither 
Agree nor 
Disagree 
Tend to 
Agree 
 
x 
Strongly 
Agree 
8   x   
9   x   
      
10                        Please use this space to answer this question: Please describe any barriers that  
      exist in your practice to measure A1c for your patients with DM:  
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Table 7                                                          PCP 2 Pre Test  
Question Number Strongly 
Disagree 
Tend to 
Disagree 
Neither Agree 
nor Disagree 
Tend to Agree Strongly 
Agree 
1     Aware of 
guideline I do  
not use it all 
of the time.  
2     x 
3     x  
4    x  
5 Yearly 
 
Monthly Quarterly 
x 
Semi-Annually 
 
Other 
6 Yearly 
x 
Monthly Quarterly 
x 
Semi-Annually 
 
Other 
7 Strongly 
Disagree 
 
 
Tend to 
Disagree 
Neither Agree 
nor Disagree 
Tend to Agree 
 
 
Strongly 
Agree 
x 
8    x  
9    x  
      
 
Tables 8 and 9 are the Post -test answers from each PCP:  
Table 8                                                            Post Test PCP 1 
Question Number Strongly 
Disagree 
Tend to 
Disagree 
Neither Agree 
nor Disagree 
Tend to Agree Strongly 
Agree 
1     Aware, and I 
like using this 
to time  
testing my 
patients A1c 
2     x 
3      x 
4     x 
5 Yearly 
 
Monthly Quarterly 
 
Semi-Annually 
x 
Other 
6 Yearly 
x 
Monthly Quarterly 
 
Semi-Annually 
 
Other 
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7 Strongly 
Disagree 
 
 
Tend to 
Disagree 
Neither Agree 
nor Disagree 
Tend to Agree 
 
 
Strongly 
Agree 
x 
8     x 
9     x 
      
10                        Please use this space to answer this question: Please describe any barriers that  
      exist in your practice to measure A1c for your patients with DM:  
 
Table 9  
 
 
 
Question Number 
  
 
 
 
Strongly 
Disagree 
Test PCP 2 
 
 
 
Tend to Disagree 
 
 
 
 
Neither 
Agree 
nor 
Disagree 
 
 
 
 
Tend to 
Agree 
 
 
 
 
Strongly 
Agree 
1     Strongly 
aware and 
am 
committed 
to using the 
guideline 
2     x 
3      x 
4     x 
5 Yearly 
 
Monthly Quarterly 
x 
Semi-
Annually 
 
Other 
6 Yearly 
 
Monthly Quarterly 
x 
Semi-
Annually 
 
Other 
7 Strongly 
Disagree 
 
 
Tend to Disagree Neither 
Agree 
nor 
Disagree 
Tend to 
Agree 
 
 
Strongly 
Agree 
x 
8     x 
9      
     x 
10                        Please use this space to answer this question: Please describe any barriers that  
      exist in your practice to measure A1c for your patients with DM:  
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 Lastly, in question 10 the PCPs were given the opportunity to identify external barriers  
that hinder their ability to adhere to the ADA guideline. The behaviors identified by the PCPs as 
barriers to their adherence to the ADA guideline are: 
1. Weather conditions. This QI project was completed in the months of January-March, 
2014. Without the option of using a mass transit system of any sort, patients in western 
Sullivan County have to drive to all medical appointments. The harsh snowy and bitterly 
cold weather prevented patients from keeping their appointments. This project recorded 
nine patients who had their A1c drawn in the baseline months, (October-December, 
2013) and then cancelled appointments they made during the QI project.  
2. Patients who fail to keep appointments. In the baseline months there were four patients 
who were identified in the sample who had been scheduled to have an appointment, but 
cancelled or did not come to the appointment. Three of these patients were captured 
during the QI project; two of these patients had A1c values ≥7% (9.0%, and 7.1%), and 
the third had a value ≤ 7% (6.2) when their A1c was tested during the QI project.  The 
values of the patient's ≥ 7% would be indicated as not adherent to the ADA guideline, 
however the PCP cannot evaluate the A1c, and treat a patient that does not present in a 
timely manner.  
3. Patients who fail to have the lab test performed. When a patient who is resistant to 
instruction is given a lab slip, yet fails to have the lab completed, the PCP is held 
accountable for not having a timely A1c value in the EHR. However, until the process of 
point-of-care A1c testing is established patient who are not adherent to PCP instruction to 
have the A1c tested remains an issue. 
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4. Lack of Reliable Transportation. Many patients, especially elderly patients have to rely 
on others for transportation to medical appointments. If the driver is unable to bring them 
appointment cancellations are unavoidable.  
Although the PCPs identified these areas of concern, the QI project was able to raise their rate of 
A1c testing in accordance to the ADA guidelines from 37% to 65%, which is a rate of change of 
28%.  
      Limitations 
 Although this QI project successfully increased the PCP ordering of the A1c in 
accordance to the ADA guideline by 28%, an additional 17% of A1c tests were ordered 
incorrectly. These were A1c values that were ≤ 7% which according to the ADA guideline did 
not need to be re-ordered for a year. This is over utilization of resources which adds cost to the 
health care system. Thus, it is evident continued education is needed to support the PCP in the 
learning process. 
 The EHR of the project settings was in the process of being upgraded in the middle of the 
QI project. The previous EHR did not have electronic flags to indicate when a test should be 
ordered. Therefore, the PCP had to rely on hand-written notes, and post-its as reminders. If one 
was misplaced, or not seen until after the patient left the office there was a missed opportunity to 
order the A1c as per the guideline. However, the new EHR will have electronic flags on the 
dashboard of each patient to indicate when testing e.g. A1c should be ordered. This should help 
the PCPs in the future.  
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 As stated by the PCPs, the effect the harsh weather encountered during the timeline of the 
QI project cannot be overstated. The unusually high snow amounts, and wind chills in the 
negative degrees for much of this project severely hampered the ability of patients to travel 
outside of their homes.  
Conclusion 
 Diabetes mellitus is the seventh cause of premature death in the United States (CDC, 
2011). PCPs must obtain a heightened awareness of the ADA Standards of Medical Care (2013) 
to reduce morbidity and mortality from diabetes. The ADA 2013 guideline specifies the need to 
perform the A1c test semi-annually on all stable diabetic patients whose A1c is ≤ 7%, and 
quarterly on all diabetic patients whose A1c is ≥ 7%.  
 In rural areas PCPs are entrusted with the medical care of patients with DM2. 
Unfortunately, as evidenced by the literature, many are not following the recommendations of 
the ADA guideline for monitoring their A1c. This disconnect is not a new phenomenon. 
Pathman, et al. identified the issue of physician non-adherence to guidelines in 1996, and 18 
years later contemporary studies continue to address non-adherence to guidelines. In addressing 
how to fill the void between guideline recommendations, and provider adherence to guidelines 
new avenues must be found. These new avenues must address the reasons for provider non-
adherence, and seek to enhance their adoption of the guideline into their practice(Pathman, et al., 
1996; Cabana, et al., 1999).  
 The challenge to PCPs in western Sullivan County is to consider a "cognitive and 
behavior change" (Pathman, et al., 1996) of awareness, agreement, adoption, and adherence 
which will lead to a paradigm shift in how primary care practitioners view, and care for their 
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Type 2 diabetic patients. The goal of this QI project was to introduce, and reinforce the use of the 
2013 ADA Guideline in Standards of Medical Care in rural, primary care settings.  The QI  
project used an educational program to: 1) educate the PCPs to the value, and importance of 
adhering to the ADA guideline to monitor the A1c of their patients with DM2, 2) educate the 
PCP to identify lack of self-efficacy to break the cycle of clinical inertia, 3) to help the PCP 
identify behaviors that effect their ability to adhere to the guideline.  
 The economic burden of diabetes lies in the elevated health care costs associated with the 
incidence of cardiovascular disease, increased incidence of infections, ophthalmologic, and 
auditory disease which are prevalent in the population of patients with diabetes (NIKKD, 2014). 
Glycemic control of ≤ 7% has been shown to reduce the incidence of these co-morbidities in 
patients with diabetes (ADA, 2013). Therefore, encouraging PCPs to adhere to the ADA 
guideline for A1c testing ensures they are managing their patients with DM2, and directly 
reducing the probability of  the co-morbidity development thereby reducing healthcare costs in 
the US. In the final analysis it is shown the PCPs were able to use the education they received to 
correctly test 65% of the patients in the sample, an overall increase of 28% adherence to the 
ADA guideline. However, the PCPs also ordered A1c tests incorrectly on 17% of their patient 
sample. Therefore, additional education is needed to support the PCP's decision when to order 
the A1c according to the ADA guideline.  
 It is anticipated continued PCP adherence to the ADA guideline will reduce the incidence 
of co-morbidities in their patient population, and thereby decrease overall healthcare costs.  
 
 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         31 
 
References 
American Diabetes Association (2013). American Diabetes Association standard of medical care 
practice guideline 2013. Diabetes, 36 (Supp 1) S11-S66 doi: 10.2337/dc13-S011 
Retrieved from: http://care.diabetesjournals.org/content/36/Supplement_1/S11.full. 
Cabana, M., Rand, C., Powe, N., Wu, A., Wilson, M., Abboud, P, & Rubin, H. (1999). Why 
don't physicians follow clinical practice guidelines?  Journal of the American Medical 
Association, 282 (15) 1458-1465. 
Davis, J., Chavez, B., & Juarez, D. (2014). Adjustments to diabetes medications in response to 
increases in Hemoglobin A1c: An epidemiologic study Journal of Pharmacotherapy 
48(1) 41-47.  
Delaronde, S. (2005). Barriers to A1C testing among a managed care population. The Diabetes 
Educator, 31 (2) 235-239.  
Glasser, M., Peters, K., Warner, J., Burkholder, P., Sharp, L., & McGee, B. (2010). 
Characteristics of diabetes patients and adherence to standards of care in rural primary 
care clinics Journal of Clinical Outcomes Management 17(8) 357-361. 
Hamilton, E.J., Martin, N., Makepeace, A., Sillars, B.A., Davis, W.A., & Davis, T. (2013). 
Incidence and predictors of hospitalization for bacterial Infection in community-based 
patients with Type 2 Diabetes: The Fremantle diabetes study. PLoS ONE 8(3): e60502. 
doi:10.1371/journal.pone.0060502. 
Huisman, T., Martis, E., Dozy, A. (1958) Chromatography of hemoglobin types on 
carboxymethylcellulose Journal of  Laboratory and Clinical Medicine 52 (2): 312–27. 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         32 
 
Institute for Healthcare Improvement (2011). Plan-do-study-act. Retrieved from: 
http://www.ihi.org/Pages/default.aspx.  
Kern, L., Barrion, Y., Dhopeshwarkar, R., Edwards, A., & Kaushal, R. (2013). Electronic health 
records and ambulatory quality of care. Journal of General Internal Medicine 28(4) 496-
203. 
Koenig, R.J., Peterson, C.M., Jones, R.L., Saudek, C, Lehrman, M., Cerami, A. (1976). 
Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. New England 
Journal of  Medicine 295 (8): 417–20. doi:10.1056/NEJM197608192950804.   
Koong, E., Gibbert, W., Garbutt, J., Sumner, W., & Brownson, R.(2013). Rural, suburban, and 
urban differences in factors that impact physician adherence to clinical preventive service 
guidelines The Journal of Rural Health 30(7-16).  
Krishna, S., Gillespie, K., & McBride, T. (2010). Diabetes burden and access to preventative 
care in the rural United States. The Journal of Rural Health 26:3-11. 
Little. R., Rohling, C. (2013). The long and winding road to optimal HbA1c measurement 
Clinica Chimica Acta 418:68-71. 
Massey, C., Appel, S., Buchanan, K., & Cherrington, A. (2010). Improving diabetes care in rural 
communities: An overview of current initiatives and a call for renewed efforts. Clinical 
Diabetes(28) 20-27. 
Mayo Clinic (2013) Diabetes Type 2: Complications. Retrieved from: 
http://www.mayoclinic.com/health/type-2-
diabetes/DS00585/DSECTION=complications. 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         33 
 
McClellan, W., Millman, L., Presley, R., Couzins, J., & Flanders, W. (2003). Improved diabetes 
care by primary care physicians: Results of a group randomized evaluation of the 
Medicare health care quality improvement program(HCQIP). Journal of Clinical 
Epidemiology 56:1210-1217.  
Nathan, D., Singer, D., Hurxthal, K., Goodson, J. (1984).The clinical information value of the 
glycosylated hemoglobin assay New England Journal of Medicine 310:341-346. doi: 
10.1056/NEJM198402093100602 
Neumiller, J., Sclar, D., Robison, L., Maldonado, A., Setter, S. & Skaer, T. (2010) Ethnicity/race 
and the extent of physician-ordered hemoglobin A1c during US office based visits by 
patients with diabetes mellitus [Peer commentary] The Diabetes Educator 36(1) 65-66. 
Parcero, A., Yaeger, T., Bienkowski, R. (2011). Frequency of monitoring hemoglobin A1C and 
achieving diabetes control, Journal of Primary Care & Community Health, 2(3) 205-208. 
Pathman, D., Konrad, T., Freed, G., Freeman, G., & Koch, G. (1996). The awareness-to -
adherence model of the steps to clinical guideline compliance: The case of pediatric 
vaccine recommendations.  Medical Care, 34(9) 873-889. 
Shaefer, Jr., C. (2006). Clinical inertia: Overcoming a major barrier to diabetes management. 
Insulin April: 2006 61-64. 
Siminerio, L., Piatt, G., & Zgibor, J. (2005). Implementing the chronic care model for 
improvements in diabetes care and education in a rural primary care practice. The 
Diabetes Educator 31(2) 225-234. 
Speri-Hillen, J., O'Connor, P., Rush, W., Johnson, P., Gilmer, T., Blitz, G., Aschf, S., & 
Ekstrom, H. (2010). Simulated physician learning program improves glucose control in 
adults with diabetes. Diabetes Care 33 (8) 1727-1733. 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         34 
 
Sullivan County Public Health Services (2013). 2013-2017 Community health assessment. 
Retrieved from: http://webapps.co.sullivan.ny.us/docs/phs/healthinfo/2013-
2017_Community_Health_Assessment.pdf. 
University of Wisconsin, Population Health Institute, Robert Wood Johnson Foundation (2013). 
County rankings and roadmaps. Retrieved from: Retrieved from: 
http://www.countyhealthrankings.org/. 
US Census Bureau (2014). State and county quick facts: Sullivan County, New York. Retrieved 
from: http://quickfacts.census.gov/qfd/states/36/36105.html.  
US Department of Health and Human Services, Agency for Healthcare Research and 
Quality(nd). National Guidelines Clearinghouse. Retrieved from: 
http://www.guideline.gov/about/index.aspx 
US Department of Health and Human Services (2003). Health information privacy: Research. 
Retrieved from: 
http://www.hhs.gov/ocr/privacy/hipaa/understanding/special/research/index.html.  
US Department of Health and Human Services, Health Resources and Services Administration 
(2013).  Find shortage areas: Health Professional Shortage Areas by State & County, 
Discipline: Primary medical care. Retrieved from: 
http://hpsafind.hrsa.gov/HPSASearch.aspx 
U.S. Department of Health and Human Services, Health Resources and Services 
Administration[HRSA](2011). Quality improvement methodology: Performance 
management and measurement  Retrieved from: 
hrsa.gov/quality/toolbox/methodology/performancemanagement/index.html 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         35 
 
US Department of Health and Human Services, National Institutes of Health, National Institute 
of Diabetes, and Digestive and Kidney Diseases (2013). Diabetes in America [2nd ed.] 
Retrieved from: http://diabetes.niddk.nih.gov/dm/pubs/america/pdf/chapter30.pdf. 
US Department of Health and Human Services, National Institutes of Health, National Institute 
of Diabetes, and Digestive and Kidney Diseases(2011). National diabetes statistics. 
Retrieved from: 
http://www.diabetes.niddk.nih.gov/dm/pubs/statistics/DM_Statistics_508.pdf. 
US Department of Health and Human Services, National Institutes of Health, US National 
Library of Medicine (2013) Medical subject headings (MeSH). Retrieved from: 
http://www.nlm.nih.gov/mesh/mbinfo.html. 
U.S. Department of Health and Human Services, National Institutes of Health, National Institute 
of Diabetes and Digestive and Kidney Diseases (2008). DCCT and EDIC: The diabetes 
control and complications trial and follow-up study (NIH Publication No. 08-3874). 
Retrieved from: http://diabetes.niddk.nih.gov/dm/pubs/control/ 
University of Wisconsin, Population Health Institute, Robert Wood Johnson Foundation (2013). 
County rankings and roadmaps. Retrieved from: Retrieved from: 
http://www.countyhealthrankings.org/ 
Vigersky, R.(2011). An overview of management issues in adult patients with Type 2 Diabetes 
Mellitus Journal of Diabetes Science and Technology 5(2) 245-250. 
Ziemer, D., Doyle, J., Barnes, C., Branch, Jr., W., Cook, C., El-Kebbi, I., Gallina, D., Kolm, P., 
Rhee, M., & Phillips, L. (2006). An intervention to overcome clinical inertia and improve 
diabetes mellitus control in a primary care setting. Archives of Internal Medicine 
166:507-5513. 
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         36 
 
  
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         37 
 
Appendix A 
PowerPoint Used in Educational Component 
Slide 1 
Chyrise E. Taylor, RN, BSN, DNP(c)
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Slide 2 
The Glycosylated Hemoglobin A1c
 The American Diabetes Association’s (ADA) 
Guidelines for Medical Practice, 2013 has established 
the glycosylated hemoglobin A1c (A1c) test as the gold 
standard in diabetes care.
 Who?
 Why?
 When?
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Slide 3 
 
WHO? WHY? WHEN?
 Who ? The 2013 Standard of Care recommends the use of 
the A1c for all patients with diabetes mellitus. 
 Why? Research has concluded the tight glucose control 
reduces the risk of complications from diabetes in the 
cardiovascular, renal, ophthalmologic, and neurological 
systems. 
 When? The ADA guidelines suggest A1c testing should be 
done semi-annually for stable patients, identified as those 
whose values are < 7.0%, quarterly for patients whose A1c is 
(≥7.0%), or three months after a treatment change to assess 
the effectiveness of the new treatment.
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Slide 4 
 
Who ?
General Patient Population 
 Diabetes Type 1- pediatric and adult patients.
 Diabetes Type 2-pediatric and adult patients.
 
 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
  
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         41 
 
Slide 5 
Who ?
Special Populations
 Pregnant Women with Gestational Diabetes.
 Other patients with diabetes: patients with HIV/AIDS, 
genetic disorders with B cell dysfunction, genetic 
defects in b-cell function, diseases of the exocrine 
pancreas (such as cystic fibrosis), and drug- or 
chemical-induced.
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Slide 6 
Why?
 NIH performed a study of 1440+ participants with 
Type 1 diabetes over 10 years. This study concludes 
intensive glucose control lowers: the risk of 
cardiovascular (57%), renal (50%), neurological 
(60%), and ophthalmologic complications (70%).
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Slide 7 
Why?
 The UK Prospective Diabetes Study by Oxford 
University performed a 20 year study from 1977-1997 
with 5000+ participants with Type 2 diabetes. This 
study concludes intensive glucose control lowers: 
nonfatal MI, CVA by 57%, fatal MI(33%), all 
microvascular disease(24%). 
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Slide 8 
Why?
 REMEMBER: When a patient’s blood sugar ≥ 7% the 
endothelial tissues of the cardiovascular, renal, 
ophthalmologic, and neurologic systems are under 
assault. 
 Patients with elevated A1c levels are prone to infection, 
and opportunistic disease.
 
 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
  
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         45 
 
Slide 9 
Why? 
 A patient’s A1c ≈ 7% translates to an average daily blood sugar of 
154 with a range of 123–185 (ADA, 2010).
 A patient’s A1c ≈ 8% translates to an average daily blood sugar of 
183 with an average daily range of 147–217(ADA, 2010).
 A patient’s A1c ≈ 9% translates to an average daily blood sugar of 
212  with an average daily range of 170–249(ADA, 2010).
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Slide 10 
When?
 Additional times to consider ordering an A1c:
 A diabetic patient with a non-healing wound.
 A diabetic patient who has visual changes.
 A diabetic patient that presents with fungal infections 
especially Candida.
 When a patient with diabetes presents with S/S 
neuropathy.
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Slide 11 
When?
 A diabetic patient who has recurrent UTIs.
 A diabetic patient who has skin infections e.g. 
carbuncles, styes, boils, folliculitis, paronychia. 
 A diabetic patient with recurrent sinusitis.
 A diabetic patient who has elevated blood pressure.
 A diabetic patient with a fracture.
 
 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
  
 Running head: THE ADHERENCE OF PRIMARY CARE                                                         48 
 
Slide 12 
What does this mean for my 
patients? 
 A current A1c can end clinical inertia on the part of the 
PCP.
 Clinical inertia is when providers recognize a problem but 
failure to act.
 Providers exhibit from clinical inertia when they are unsure 
of treatment options, or are unsure when to change 
treatments, or question patient adherence to treatment 
options.  
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Slide 13 
How Can I End Clinical Inertia?
 A current A1c is an objective clinical indicator of the 
patient’s glycemic control.
 A current A1c can be the basis for beginning a 
conversation with a patient about their glycemic 
control.
 A current A1c is the starting point for the PCP to 
decide if current treatment should be intensified, or 
continued.
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Slide 14 
How Can I End Clinical Inertia?
~Remember:
 A patient’s A1c ≈ 7% translates to an average daily blood 
sugar of 154 with a range of 123–185.
 A patient’s A1c ≈ 8% translates to an average daily blood 
sugar of 183 with an average daily range of 147–217.
 A patient’s A1c ≈ 9% translates to an average daily blood 
sugar of 212  with an average daily range of 170–249.
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Slide 15 
Remember:
 Each year that a patient’s A1c is over 7% increases the 
risk of complications of:
 CAD: High blood pressure, CHF, PVD. 
 Neuropathy: Peripheral and autonomic. 
 Renal failure: May lead to dialysis.
 Other: hearing loss, gum disease. 
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Slide 16 
When a patient with diabetes 
comes in:
Is a current A1c in the HER?
No, order an A1c
The result is
less than 7%;   
order another 
A1c in
6 months.  
The result is 
more  than 7%;  
adjust the 
diabetes regimen 
and re-order in 3 
months
Yes, and it is 
less than 7% 
The patient is 
therapeutic , re-
order another 
A1c in 6 months. 
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Slide 17 
QUESTIONS?
Thank you for agreeing to 
participate in this project!
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Slide 18 
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